The EC has granted expanded approval to BMS' Breyanzi, to treat adults with relapsed or refractory follicular lymphoma (FL).

An early pilot trial suggests that combining atezolizumab (tecectriq) with rituximab (Rituxan), gemcitabine (gemzar) and ...

Koalas from a population north of the Brisbane River have evolved a unique genomic immunity to the killer retrovirus ...

The following is a summary of “Hematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre propensity-score matched study,” published in the March 2025 issue of Journal of the ...

A longitudinal multiomics analysis of a patient with multiple myeloma who developed peripheral T cell lymphoma after treatment with anti-BCMA CAR T cells and a GPRC5D-directed bispecific antibody ...

T-cell lymphoma is a rare cancer that affects the lymphatic system. Learn about the types, signs, symptoms, treatments, and ...

How Did the Tattoo-Cancer Study Work? The Departments of Public Health and Clinical Research at the University of Southern ...

Doctors group B-cell lymphomas based on: How the cancer cells look under a microscope Whether the cancer cells have certain proteins on their surface What kinds of gene changes are inside the ...

This type of lymphoma is often designated as low grade because it doesn't have a tendency to be very aggressive. There are other types of eye cancer that aren't lymphomas, such as retinoblastoma and ...

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has issued Final Draft Guidance recommending the use Breyanzi (lisocabtagene maraleucel) for National Health ...

What recent advancements in CAR T-cell therapy are you most excited about, especially in treating lymphomas? The advancements in CAR T-cell therapy, particularly for treating lymphomas ...